522 related articles for article (PubMed ID: 31072396)
1. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
3. Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021.
Jackson S; Kabir Z; Comiskey C
Vaccine; 2024 Mar; 42(8):2099-2105. PubMed ID: 38423810
[TBL] [Abstract][Full Text] [Related]
4. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.
Kelly P; McKeown D; Clancy L
Eur Respir J; 1997 Mar; 10(3):619-23. PubMed ID: 9072995
[TBL] [Abstract][Full Text] [Related]
5. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada.
Cook VJ; Hernández-Garduño E; Kunimoto D; Hershfield ES; Fanning EA; Hoeppner VH; Elwood RK; FitzGerald JM;
Can Respir J; 2005 Apr; 12(3):134-8. PubMed ID: 15875064
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
[TBL] [Abstract][Full Text] [Related]
7. Non-specific effects of BCG vaccination on morbidity among children in Greenland: a population-based cohort study.
Haahr S; Michelsen SW; Andersson M; Bjorn-Mortensen K; Soborg B; Wohlfahrt J; Melbye M; Koch A
Int J Epidemiol; 2016 Dec; 45(6):2122-2130. PubMed ID: 28338723
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
9. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
10. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
[TBL] [Abstract][Full Text] [Related]
11. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
[TBL] [Abstract][Full Text] [Related]
12. The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
Fack C; Wood R; Hatherill M; Cobelens F; Hermans S
Vaccine; 2022 Jan; 40(2):364-369. PubMed ID: 34872798
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic impact of a specific BCG vaccination program implemented in Prato, central Italy, involving foreign newborns on hospitalizations.
Bellini I; Nastasi A; Boccalini S
Hum Vaccin Immunother; 2016 Sep; 12(9):2383-90. PubMed ID: 27184892
[TBL] [Abstract][Full Text] [Related]
14. [Progress in research of bacillus calmette-guerin vaccination and repeated vaccination].
You NN; Liu Q; Zhu LM; Lu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1519-1523. PubMed ID: 30462965
[TBL] [Abstract][Full Text] [Related]
15. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
16. BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
Bennasrallah C; Kacem M; Dhouib W; Zemni I; Ben Fredj M; Abroug H; Djobbi A; Green A; Said SG; Maalel I; Stambouli S; Zhir W; Youssef HBH; Sriha Belguith A
PLoS One; 2019; 14(8):e0219991. PubMed ID: 31381577
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
18. Paediatric tuberculosis during universal and selective
Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.
Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K
BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503
[TBL] [Abstract][Full Text] [Related]
20. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan.
Bowerman RJ
Int J Tuberc Lung Dis; 2004 Oct; 8(10):1228-33. PubMed ID: 15527155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
